are glp 1 drugs dangerous How long should you take GLP-1 drugs? Study links longer use to lower heart risk Obesity drugs: huge study identifies

As drugs become more available, equitable access to these treatments should be prioritised to meet the needs of all population groups, particularly those who may face barriers to access despite high interest

Direct head-to-head comparisons have not been done

10-year incidence of diabetes and associated risk factors in Greece: the ATTICA study (2002-2012) Rev Diabet Stud

doi: 10.1503/cmaj.101281 Summary Keywords sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, type 2 diabetes, metformin, meta-analysis Citation Deng R, Mei K, Song T, Huang J, Wu Y, Yu P, Yan Z and Liu X (2024) First-line treatment with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in type 2 diabetic population at low risk of cardiovascular disease: a meta-analysis

GLP-1 receptor agonists are useful, injectable drugs for the treatment of T2D as they improve glycemic control and atherosclerosis-related parameters [17-26]

In this guide, were going to explain how Ozempic and other GLP-1 receptor agonists work so you and a health care professional can make an informed decision about whether or not its the right option for you